Thanks, Bob, and good afternoon, everyone. I will now briefly discuss our financial results for the quarter ended March 31, 2026. Revenue for the first quarter of 2026 was $1.1 million compared with $1.3 million for the first quarter of 2025. The decrease from prior year was primarily attributable to HSN's transition to a new apparel supplier for our C. Wonder and Christie Brinkley brands in the fourth quarter of 2025, which caused a temporary gap in wholesale shipments and negatively impacted sales for these brands and our associated licensing revenues during the current quarter. Direct operating cost and expenses were $2.1 million for the current quarter, down from $2.3 million in the prior year quarter. This decrease from prior year was primarily attributable to cost reduction actions taken by management during 2025, which reduced payroll and benefit costs. Looking at our other operating costs and expenses, which were all noncash in nature, during the current quarter, we recognized a small impairment charge of $61,000 to write down the value of the Judith Ripka trademarks, which we then subsequently sold in April for $2.3 million in cash plus future earn-out consideration. Our depreciation and amortization expense for the current quarter was essentially flat from the first quarter of last year at approximately $0.9 million. Also on the prior year quarter notably included approximately $0.3 million of equity method losses and other related charges and adjustments for equity investment on IM Topco, which we were to dispose of in the fourth quarter of last year. Interest and finance expense was approximately $0.59 million in the current quarter, up slightly from $0.56 million in the first quarter of last year. As you may recall, However, under our term loan agreement, a majority of the interest due under our current debt will be paid in kind, meaning that it will accrue and not require cash payments until starting 2027. Overall, we had a net income loss for the current quarter of approximately $2.5 million or minus $0.42 per share compared with a net loss of $2.8 million or minus $1.18 per share in the prior year quarter. After adjusting for certain cash and noncash items, results on a non-GAAP basis were a net loss of approximately $1.4 million or minus $0.24 per share for the current quarter and a net loss of approximately $1.4 million or minus $0.58 per share for the prior year quarter. Adjusted EBITDA loss for the current quarter was approximately $700,000, essentially flat from the prior year. Once again, as a reminder, our earnings press release and Form 10-Q present a full reconciliation of our non-GAAP measures of the most directly comparable GAAP measures. Now turning to our balance sheet and liquidity. As of March 31, 2026, the company's balance sheet reflected stockholders' equity of approximately $13 million, restricted cash of $1.1 million and unrestricted cash of approximately $0.2 million. I would also like to note that we have significant financing activity during the first quarter of 2026, extending into the month of April. In January 2026, we entered into a committed equity line facility given us access up to $15 million of funding over the next 2 years for working capital and potential acquisition opportunities at our discretion. To date, we have not utilized any funding under this facility. In February and March of this year, we executed certain amendments to our term loan debt, which set the stage for a significant debt financing transaction in April. In April, we paid a portion of our variable interest rate term loan debt and entered into $3 million of senior secured notes at a fixed interest rate. And with that, I'd like to turn the call back over to Bob. Bob?